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Introduction
Australian community physiotherapists mostly operate as
primary contact practitioners, with an estimated 90% of
their contacts related to the musculoskeletal system
(Grimmer et al 1998). Analgesics and non-steroidal anti-
inflammatory drugs (NSAIDs) are the most common
pharmaceuticals for alleviating the pain and reduced
function of musculoskeletal conditions (Moore et al 1998). 
Concerns have been formally expressed in Australia
regarding physiotherapists’ role in drug administration
since 1992 (New South Wales Physiotherapists
Registration Board 1996 Policy Statement). As a result of
these concerns, Lansbury and Sullivan surveyed practising
NSW physiotherapists in 1996 regarding their knowledge
of, and involvement with, patient medications (Lansbury
and Sullivan 1998, Sullivan and Lansbury 1999). This
study highlighted the need for better physiotherapy
education regarding, among other medications, NSAIDs
use, indications, contraindications, drug interactions and
side effects. The result of this survey was a policy
statement by the NSW Physiotherapists’ Registration
Board reminding physiotherapists of their responsibilities
under the (then) legislation (New South Wales
Physiotherapists’ Registration Board Policy Statement
1996). The influence of this action was not evaluated in
other states in Australia. Due to the independence of state
physiotherapy registration boards in Australia, it is likely
that the policy statement would have had very little
influence on practice behaviours elsewhere. 
A further reminder to physiotherapists of their
responsibility under the legislation came in the form of a
Letter to the Editor published in the members’ newsletter of
the South Australian Branch of the Australian
Physiotherapy Association (APA) newsletter, written by a
representative of the Drugs and Poisons section of the
Department of Human Services following a patient
complaint (McKellar 1999). This letter outlined the
relevant scheduling of NSAIDs under the Controlled
Substances Act 1984 and the Controlled Substances
(Poisons) Regulations 1996, and the limitations this Act
and Regulation placed on physiotherapists supplying
NSAIDs to clients. 
Recently, there has been a change in the scheduling in
Australia of some NSAIDs, from medical prescription only
to non-prescription status, which now allows these
NSAIDs to be sold over the counter in supermarkets and
pharmacies. Despite the recognition of the role of
physiotherapists in quality medications use by patients
(Lansbury and Sullivan, 1998, McKellar 1999, Sullivan
and Lansbury 1999), the change in scheduling of NSAIDs
has not been accompanied by concerted attempts to
educate physiotherapists about how their responsibilities
may have changed. Thus, the combination of more freely
available NSAIDs being commonly used as adjuncts to
physiotherapy treatment (Moore et al 1998), leads to an
increased potential for medication misuse and
misadventure.
This paper reports on findings from a study which
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collected current information on knowledge, treatment
behaviours and attitudes of Australian physiotherapists
regarding the use of NSAIDs in clinical practice (Grimmer
and Gilbert 2001).  We intend to use this information to
determine whether there is a need for specific education for
physiotherapists on NSAIDs, and if so, what the focus of
that education should be.
Method
Preliminary information Preliminary framing information
was sought for this project. All Schools of Physiotherapy in
Australia were contacted regarding the number of hours
and content of pharmacological training offered to
undergraduate and postgraduate students. The
physiotherapists registration boards in each state were
contacted regarding their interpretations of, and advice to,
physiotherapists on the Standard for the Uniform
Scheduling of Drugs and Poisons No 14 (Australian Health
Ministers Advisory Council 1999). 
Project support Steering and reference committees were
convened to guide the conduct of the study and the
interpretation of its findings. The Steering Committee
comprised experienced physiotherapy practitioners from
each of the three surveyed states and territory (South
Australia, Tasmania and the Australian Capital Territory
(ACT)). The Reference Committee comprised
representatives of the APA and state registration boards, a
consultant pharmacist, the head of a School of
Physiotherapy, a health economist and a surveyor of the
APA’s Quality Endorsement Programme. 
Development of the survey instrument In-depth semi-
structured telephone interviews were conducted by one of
the research team involving 30 physiotherapists in the
participating states/territory. The participating
physiotherapists were identified by members of the
Steering and Reference Committees as having specific
interests or experiences in NSAID use. This aspect of the
research was conducted in the manner described by Rice
and Ezzy (1999). The purpose of the interviews was to
construct a conceptual framework of physiotherapists’
knowledge and attitudes to NSAID use in clinical practice.
Key themes, concepts and words were synthesised from
these interviews and formed the basis for the development
of a written survey instrument. 
This aspect of instrument development highlighted the
difficulties of interpreting practice behaviours that were
collected using categorical (graded) responses, as
discussions with physiotherapists indicated significant
differences in interpretation of categories. As the purpose
of this survey was to determine and define the education
needs of physiotherapists regarding NSAIDs, binary
responses to questions was considered to be more valid and
useful than attempts to grade information elicited by the
survey instrument.
Survey instrument (Appendix) A draft written survey
instrument was subsequently designed from the interview
findings. Four sections were developed: 
• physiotherapist demographics
• knowledge of NSAIDs and their quality use
• current use of NSAIDs in clinical practice 
• attitudes to the use of NSAIDs in clinical practice. 
The survey instrument consisted of free text and checklists
(including correct and incorrect answers to questions), and
was limited to two double-sided A4 pages to facilitate
efficient completion. One of the research team  provided
the correct answers to the checklist questions in the survey
that tested physiotherapists’ knowledge on aspects of
NSAID administration. The respondents’ answers could
then be compared with the correct responses, and the
percentage that were correct, incorrect or unknown
reported. Physiotherapists’ knowledge of legislation
regarding NSAID use in clinical practice was tested in a
question with set responses. We were reluctant to suggest
correct answers for these questions because of the
differential interpretations of the words “use” and
“recommendations” between the Poisons Act and
registration boards’ information to physiotherapists. 
The instrument was tested for face, content and construct
validity, using iterative processes outlined by Carmines and
Zeller (1979) and Hunt et al (1982). The steps were:
1. Each member of the Steering Committee trialled the
questionnaire on 20 practising physiotherapists in
their own state, for usability, ease of completion and
omissions.   
2. On the basis of the responses from these
physiotherapists, the research team made changes to
question wording, layout, content and intent.
3. The revised survey instrument was returned to the
Steering Committee for comment, again resulting in
changes to question wording, layout, content and
intent.
4. The resultant questionnaire was sent to the Reference
Committee and to all members of staff and higher
degree students in the School of Physiotherapy,
University of South Australia for: 
• comment on design, usability and layout, and
• completion to test usability and response range. 
Further refinements were made to the instrument, with the
resultant document being again circulated to the Steering
Committee for comment. The final version of the
questionnaire was agreed by the research team and the
Steering Committee in early September 2000, and is
provided as an appendix to this paper. 
Subjects A random selection of 50% of the registered
physiotherapists in South Australia, Tasmania and the ACT
was surveyed by mail with this instrument. Randomisation
was by computer generated selection from a list of all
currently registered physiotherapists in the two states and
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one territory. This process, and the subsequent mail-out of
the survey instrument, was conducted independently by the
registration board clerical staff in each state and territory.
As responses to the questionnaire were also anonymous,
the research team thus remained independent of the
sampling and recruitment process, and of who had
responded in each state. Reply paid envelopes were used to
facilitate questionnaire return directly to the Centre for
Allied Health Research, University of South Australia.  
The states of South Australia and Tasmania, and the ACT
were chosen to reflect a range of practice locations.
Physiotherapists in the ACT reflect generally urban or large
rural practice, situated at several major sites, whilst
physiotherapists in South Australia and Tasmania reflect a
mix of urban, large and small rural and remote practice
(AIHW Physiotherapy Workforce Document 2001). Table
1, in the Results Section, allows comparison of this data,
with the respondent’s workplace. 
A total of 750 questionnaires were sent: 150 in Tasmania,
450 in South Australia, and 150 in the ACT. Responses
were collated by state and major place of work.  
Data analysis Quantitative data was analysed by
frequency of response to each question, in most instances
as a percentage of the total number of responses to each
question. This accounted for multiple responses that could
be provided by participants. Differences were tested
between response locations by comparing proportions
using the Chi square statistic, or differences between
means, as appropriate. Qualitative data (the text responses)
were analysed for key themes and concepts and the
frequency of these was also reported. As described
previously, differences were sought between the nature and
the frequency of responses, between response locations. 
The aim of analysis was to establish whether there was a
need for the development of an education package for
physiotherapists, and if so, which areas this package would
need to address. 
Results
Preliminary investigations 
Our survey of physiotherapy schools, the APA and state
registration boards suggested that the up-to-date training in
the quality use of medicines by physiotherapists in
Australia is not comprehensively or standardly addressed at
either tertiary training (undergraduate or postgraduate
levels) or in professional continuing education following
graduation. There is no competency standard for
pharmaceutical education for graduating physiotherapists
and there is no standard content of curriculum on
pharmaceutical training at undergraduate, postgraduate or
professional development levels. There are also variable
interpretations between states of the Standard for the
Uniform Scheduling of Drugs and Poisons No 14
(Australian Health Ministers Advisory Council 1999),
highlighting a number of “grey” areas of interpretation
within definitional contexts. Thus there appeared to be
little guidance for physiotherapists in appropriately and
correctly dealing with NSAIDs in clinical practice. This
finding supported the need for our project to establish
current practice and understanding by physiotherapists of
NSAIDs in the clinical setting. 
Response to survey and subject demographics  
Responses to the survey instrument were obtained from
285 physiotherapists in total, representing an overall
response rate of 38%. The response rate in each state was
similar, and there were no differences between
states/territory in proportion of responses to any of the
questions reported in this paper.  We compared our sample
with physiotherapy workforce information (Australian
Institute of Health and Welfare (AIHW) workforce data
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Figure 1. The frequency with which respondents had
updated their knowledge on NSAID use.
Table 1. Comparison between state workforce data and
workplaces reported in our sample.
Private Hospital Aged
practice practice care
AIWH SA 47% 24% 21%
SA response 60% 29% 11%
AIWH Tas 44% 33% 14%
Tasmania response 48% 27% 25%
AIWH ACT 48% 31% 17%
ACT response 67% 16% 16%
AIWH (All Aus) 44% 33% 15%
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from 1998) to determine the generalisability of our sample
responses. The AIHW physiotherapy workplace data is
reported in more categories than were used in our study.
Table 1 compares the responses from our study for primary
place of work with the AIHW data. The hospital practice
figures provided by AIHW were directly transferable to our
study. This table indicates that the proportion in our sample
were representative of the proportions in the 1998
physiotherapy workforce. 
Knowledge about NSAIDs
Recent updating of knowledge on NSAIDs Only 16% of
respondents reported updating their knowledge on NSAIDs
within the past year, with 32% of respondents having
updated their knowledge within the past one to five years.
Given the recent change in scheduling of NSAIDs, this
suggests that the majority of respondents were unlikely to
have current knowledge on NSAID sale, use, contra-
indications or legislation pertaining to physiotherapists.
The percentage of respondents in categories of time since
update is provided in Figure 1. Of the respondents who had
updated their knowledge over the last five years, 45% of
respondents had actively sought this information. Multiple
answers were provided to this question, and of the total
number of responses, the most common sources of
information were MIMS (34%), general medical
practitioner (27%), local pharmacist (16%), training
schools (15%), journal articles (15%), another
physiotherapist (14%) and variably from advertising, drug
company representatives and the registration board (7% or
less). 
Knowledge on NSAIDs Correct information on
where/how to obtain a range of NSAIDs (reflecting drugs
in Schedules 2, 3 or 4) was demonstrated by 84% of
respondents, with incorrect answers provided by 6%, and
the remainder of respondents indicating that they did not
know the answer. 
Respondents were asked to identify up to three conditions
for which NSAIDs were appropriate, with 99% of the 451
responses being correct. The most common correct
responses were osteoarthritis (29% of the total number of
responses), musculoskeletal injury (11%), rheumatoid
arthritis (11%), spinal pain (10%) and joint strain (10%). 
When asked to identify up to four side effects of oral
NSAIDs, respondents expressed generally good
knowledge, with 89% of the 664 text responses being
correct. The most common correct side effects reported by
respondents to this question were upper gastrointestinal
tract problems (31%), ulcers (22%) and bleeding (15%).
However, when asked the same question about the side
effects of topical NSAIDs, respondents’ knowledge was not
as extensive or accurate. There were only 65 responses in
total to this question, with 71% correct answers. The most
common correct side effects reported by respondents to
this question reflected the information provided for oral
NSAIDs, being upper gastrointestinal tract problems
(17%), ulcers (11%) and bleeding (9%). 
Eighty per cent of respondents reported being aware of
adverse reactions by at least one of their patients to
NSAIDs. The most common adverse reactions reported by
respondents were gastric disturbances (24%), nausea
(17%) and stomach ulcer/bleeding (13%). 
Knowledge of legislation Physiotherapists’ knowledge of
legislation regarding NSAID use in clinical practice is
reported in Table 2. The high percentage of “don’t know”
answers and the incorrect ones for each of the items in the
question indicates the need for more education for
physiotherapists on the current legislative position
regarding NSAIDs. As with knowledge of side effects and
appropriate use of NSAIDs, any inaccuracies in the
knowledge physiotherapists have about legislation could
have potentially serious consequences. Thus this section
provides the basis for education material that will ensure
physiotherapists will have appropriate knowledge on
NSAID use. 
NSAID use in clinical practice  
Approximately fifty-five per cent of the respondents
reported that they regularly recommended NSAIDs directly
to their patients, and often by brand name. Over-the-
counter topical NSAIDs were the most popular
recommendations (83%), followed by over-the-counter oral
NSAID recommendations (78%). Recommendation that
the patient consult a general medical practitioner regarding
NSAID purchase and use was reported by 64%
respondents. All of the physiotherapists who did not
directly recommend NSAIDs to their patients referred
patient enquiries to their general medical practitioner, and
81% of them also referred patients to a pharmacist.
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Table 2. Physiotherapists’ knowledge of the legislation regarding NSAIDs.
Legislation allows Answer left blank Don’t know
Physiotherapists to advise on the use of NSAIDs 50.6% 5.7% 43.7%
Physiotherapists to prescribe NSAIDs 51.0% 0.8% 48.1%
Physiotherapists to recommend NSAIDs 60.0% 6.3% 33.7%
Physiotherapists to supply oral NSAIDs 40.8% 5.4% 53.8%
Physiotherapists to supply topical NSAIDs 48.6% 11.6% 39.9%
Physiotherapists to use NSAIDs in patient treatment 54.5% 6.3% 39.2%
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Additional recommendations provided to patients by
physiotherapists included warnings/advice (96%),
contraindications for use (85%), precautions (96%),
prescriptions (70%), drug interactions (26%), side effects
(84%), dosage (44%) and brand names (61%).  Discussions
with patients regarding NSAIDs were regularly recorded
on patient notes by 65% of respondents. 
Approximately 20% of respondents reported regularly
using topical NSAIDs as massage cream and/or as an
electrotherapy contact agent. Although the question was
not directly asked, text comments provided by 10% of
respondents indicated that they discussed the application of
topical NSAIDs prior to administration during treatment. 
Attitudes to physiotherapist prescription and supply of
NSAIDs  Responses to the questions on physiotherapist
prescription and supply of NSAIDs produced significant
support (67% of respondents) for the current legal position
(that is physiotherapists should not prescribe NSAIDs).
This was counterbalanced by a strong case from a group of
respondents who were in favour of change to the legislation
to allow physiotherapists to prescribe and supply NSAIDs.
These responses came from private practitioners in rural
and metropolitan areas (18%). The remainder of
respondents did not express an opinion.   
Responses to the questions regarding whether current
knowledge of NSAIDs was sufficient to allow
physiotherapists to appropriately advise patients, indicated
that 72% of respondents disagreed and 16% agreed. This
figure reflected those physiotherapists who wanted the
legislation changed to allow them to prescribe NSAIDs.
The remainder did not express an opinion. 
The question regarding who should take responsibility for
providing information on NSAIDs to physiotherapists
identified a number of possible sources of update
information, probably reflecting the specifics of places
and/or people from which physiotherapists currently obtain
information. These are listed in Table 3. 
Discussion
Response rate and polarisation The response rate to this
survey was disappointing in light of that reported in the
1996 study of physiotherapist involvement with
medications (Lansbury and Sullivan 1998). It was,
however, of the same order of studies of practice
behaviours conducted by the Australian Prescriber (Bloom
1993, Bloom and Associates 1997) and falls within the
range of responses in other published surveys of
physiotherapists (Butler and Sheppard 1999, Ladyshewsky
et al 1996, Michaeli 1993, Turner and Whitfield 1997). The
response rate also reflects the current expected response
rate from general medical practitioners to surveys
regarding quality of practice and practice behaviours (Clare
and Hofmeyer 1998). We further suspect that a reason for
our low response was that selection of our sample was from
the complete list of registered physiotherapists in each
state, which means that a proportion of the questionnaires
would have gone to non-practising clinicians, or
physiotherapists working overseas. 
The proportional representation in this survey of
physiotherapists practising privately, in hospital (inpatient
or outpatient) or aged care does not differ substantially
from the proportional workforce representation in the all-
Australian data, or in the individual state data published by
the AIHW from its 1998 survey (AIHW Workforce Data
1998). The small differences observed between the
percentage of physiotherapists in these main categories of
practice in our data and the AIHW data possibly relate to:
• Our survey request for information on participant’s
current “most time” activity (therefore not capturing
information on secondary areas of practice);
• Our use of only four possible categories of workplace
activities (private practice, hospital inpatients and
outpatients, and aged care/community settings); and
• Change in workforce activities since the AIHW data
was collected. 
Despite these differences, we believe that our sample
appropriately represents the major areas of clinical
physiotherapy practice, and thus identifies the needs of
physiotherapists in a range of clinical practice settings for
education on NSAIDs. 
We acknowledge the potential for bias in responses by
physiotherapists to this survey, as responses were clearly
polarised into two groups: physiotherapists who wanted no
change from the status quo; and physiotherapists who
desired significant changes in legislation to allow them to
prescribe and sell NSAIDs. There were very few equivocal
responses to the attitudinal questions, suggesting that
respondents indeed had fixed views on NSAID use and
their role in NSAID use by patients. Thus, our survey
achieved its purpose, in that it elicited information that
outlined the current educational needs of physiotherapists
regarding NSAIDs in clinical practice, and highlighted a
range of issues that need to be addressed in an education
program.   
Grimmer et al: Non-steroidal anti-inflammatory drugs (NSAIDs): Physiotherapists’ use, knowledge and attitudes
Table 3. Who should take responsibility for providing
updates on information to physiotherapists on NSAIDs? 
Training schools 71.6%
Physiotherapists themselves 65.3%
Australian Physiotherapy Association 64.2%
Physiotherapy conferences 55.8%
Drug companies 39.6%
Physiotherapists registration board 28.8%
General practitioners 22.8%
Local pharmacists 18.9%
NB multiple answers are reflected in these response rates
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The need for education of physiotherapists regarding
medication This study identified that little has changed
since Lansbury and Sullivan undertook their survey in
1996 regarding physiotherapists’ knowledge of the quality
use of medicines (Lansbury and Sullivan 1998). Little time
continues to be spent in undergraduate and postgraduate
training programs in Australian universities in educating
students about the quality use of medications, in particular
NSAIDs as an adjunct to physiotherapy practice. Moreover,
there have been few continuing education opportunities in
this area provided in the past five years in the three states
we surveyed, for practising physiotherapists. The recent
change in scheduling of NSAIDs from prescription to over-
the-counter purchase, and increased potential that this
introduces for medication misadventure by physiotherapy
patients, adds weight to the need for specific education
programs targeted at physiotherapists’ responsibilities in
responding appropriately to patient queries on medications
during treatment sessions. 
Dilemmas in maintaining the status quo This study
highlighted multi-dimensional dilemmas for
physiotherapists. The recent rescheduling of NSAIDs
means that any adult can now purchase a range of NSAIDs
over the counter, for their own use. The descriptions of
Schedules 2 and 3 in the Commonwealth Act deliberately
use the word “safe”, with an expectation that informed
advice is provided at point of sale by a suitably licensed
person (pharmacist or pharmacy assistant). It appears that
the intention of Schedules 2 and 3 drugs are that the
purchaser will be the user, and will use the drug in full
knowledge of its effects, interactions, contraindications and
side effects (informed use). 
Thus, physiotherapists can purchase NSAIDs in the same
way as any other individual, for personal use. The dilemma
arises when physiotherapists extend the intention of the
Controlled Substances Act (1984), and assume a role for
which they are not adequately qualified. In this context,
there are a number of opportunities for breaching the duty
of care of physiotherapists to their patients. The three main
opportunities that we have identified from this study are
when physiotherapists: 
1. Recommend NSAIDs to patients.
Patients, because of their respect for the role of
physiotherapist in the community as an educated
primary health care provider, could well take this
recommendation as being provided by a suitably
licensed person (which the physiotherapist is not, in
the letter of the law). This recommendation could be
taken by patients to be based on better information,
than that provided by a neighbour or friend.
Appropriate licensing assumes that the
physiotherapist would be aware of the
contraindications, interactions and indications for the
use of NSAIDs, and could make safe and effective
recommendations on NSAID use in the full
knowledge of the patients’ overall medical status. It
thus assumes that the physiotherapist is in a position
to inform the patient adequately about drug use. We
believe from the responses to our survey that few
physiotherapists are in possession of this knowledge,
and have minimum access to up-to-date information
regarding quality use of NSAIDs that could be passed
on appropriately to patients.  
2. Purchase NSAIDs for use in patient care, therefore
abrogating the intention of the NSAID scheduling that
the purchaser is the user. 
Responses to our survey indicate that the adjunct use
of NSAIDs by physiotherapists in their clinical
practice (in particular the application of topical
NSAIDs for massage or electrotherapy) is on the
understanding that the administration of the drug will
enhance the effectiveness of other physiotherapy
techniques. This may occur without patient consent.
There is a lack of evidence in the literature of an
enhancing effect of NSAIDs when coupled with other
physiotherapy modalities, and therefore
physiotherapist use or recommendation of NSAIDs in
this capacity is without convincing foundation. The
evidence for increased clinical efficacy of commonly
available topical preparations of NSAIDs when used
in conjunction with ultrasound (ie phonophoresis)
remains unconvincing (Benson et al 1989, Klaiman et
al 1998, Penderghest et al 1998, Sevier and Wilson
1999).
3. Sell NSAIDs in their clinics, therefore physiotherapy
practices become a place of sale, and point-of-sale
expert advice should be available. The issue of
suitable licensing of the seller is highlighted in this
instance, in conjunction with direct contravention of
the Poisons Act and registration board
recommendations.
Dosage and side effects We anticipated that the side
effects for oral and topical NSAIDs would have been
mentioned by respondents with the same frequency and
accuracy. Side effects for both forms of NSAID
administration are almost identical, as the same
pharmacological mechanisms are at work with topical as
with oral NSAIDs, although the risk is less with topical
preparations because of dosage (Vaile and Davis 1998).
The only significant difference in side effects is secondary
to the transdermal application of topical preparations ie a
greater risk of skin reactions with topical agents. However,
we found significantly fewer responses, and a lower
accuracy of responses for the question regarding side
effects of topical NSAIDs, when compared with the
question regarding oral NSAIDs. From this we inferred that
physiotherapists required educating regarding the action of
topical NSAIDs and the associated side effects that could
be expected.  
The dose of NSAIDs is relatively controlled when it is in
oral format. The dose of topical agents is not as obvious,
and depends on the frequency and amount of
administration. As topical agents act in the same systemic
pathways as ingested medication, topical NSAIDs do not
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need to be applied to the local site of inflammation to be
effective. Hence the treating physiotherapist is less able to
control the dose provided to either the patient, or to
him/herself, particularly when the topical agent is used as a
massage cream. A number of text responses provided by
respondents indicated that they believed that topical agents
acted as a placebo only. This assumption was underpinned
by the small number of responses to the question of risks
associated with topical agency administration. This
perception is contradicted by the findings of a recent
systematic review of topically applied NSAIDs (Moore et
al 1998), where “In acute conditions like strains and
sprains, topical NSAIDs were significantly better than
placebo over a one week period. In chronic conditions like
arthritis and rheumatism, topical NSAIDs were
significantly better than placebo over two weeks” 
(p. 338). 
Physiotherapists’ responses regarding their involvement
with NSAID use in the future There were two clear views
expressed in this study. One view, reflecting private
metropolitan and rural practitioners, reflected a strong
desire to be allowed to on-sell, actively recommend and
even prescribe NSAIDs as part of their clinical practice.
The rural practitioners particularly highlighted issues of
non-availability of medical and other health services in the
country, to provide the “back up” to physiotherapy
practitioners regarding medications that would be routinely
expected in the urban regions. Furthermore, many patients
of private physiotherapists may not consult a medical
practitioner for problems that they perceived to be best
addressed by the physiotherapist. Such conditions were
commonly sports injuries or spinal pain. The perception
from physiotherapists responding to our survey was that
patients desired a “one-stop shop” where the appropriate
management for their condition could be provided in the
one consultation. 
The opposing view was expressed by respondents who
wanted more involvement with NSAID use in clinical
practice, but were comfortable being guided at all times by
medical practitioners and/or pharmacists. This group
commonly recognised the difficulties of understanding
their patients’ overall medical status and their lack of
adequate knowledge and training in dealing with patients’
medications, but identified that they often played a key role
in assessment of patient needs and physical problems. For
instance, there were a number of comments regarding
difficulties in dealing with patients using multiple
medications (particularly in the elderly population with
multiple conditions, who were attending the
physiotherapist for only one of these conditions). 
Education package This study identified and clarified the
need for a standard, independent and up-to-date education
package on quality use of NSAIDs tailored to
physiotherapy practice and patient type. Respondents to
our survey indicated that they accessed variable sources of
information on NSAIDs, with MIMS and general medical
practitioners being the source of information for many
physiotherapists. However, the most common source of
general medical practitioner knowledge of drugs has been
reported to be drug company representatives (Roughead et
al 1998b, 1998c). Thus there appears to be a need for
regular educational presentations on quality use of
medicines at physiotherapy meetings, and also for regular
publication in academic journals and professional
newsletters of changes in scheduling of medications and
the implications of this for physiotherapy practice.
Conclusions and recommendations
Our survey identified key areas for enhancing the
education of physiotherapists at undergraduate,
postgraduate and continuing (post graduation) professional
practice levels in the quality use of NSAIDs. We are now
completing an education package that can be used to
update and maintain physiotherapy knowledge on quality
NSAID delivery. Moreover we have made a number of
recommendations from this survey that have not only
educational but also moral and professional implications
for the profession. These recommendations are that:
1. The opportunity be overtly recognised in
physiotherapy undergraduate and postgraduate
training for pharmaceutical misadventure in the use of
NSAIDs by patients with musculoskeletal problems,
particularly when:
• these medications are purchased by patients over
the counter in pharmacies and supermarkets, and
self administered based purely on physiotherapists
advice, or 
• administered in conjunction with physiotherapy
treatment without patient consent or proper risk
assessment.  
2. There be recognition by physiotherapists, the APA, the
state registration boards and physiotherapy training
institutions, of the ethical and legal implications of
physiotherapists recommending, selling and/or using
NSAIDs in their clinical practice, under the current
legislation. Even when NSAIDs are Schedule 2 or 3
drugs (and therefore the responsibility for purchase
and use is the patient’s), it is likely that patients
consider physiotherapists to be more informed on
NSAID use than neighbours, friends or pharmacy
assistants, and thus may be more likely to act on
physiotherapy advice without exercising due personal
consideration of risks or contraindications which are
outlined on the packaging of the drug.   
3. There be overt recognition by medical specialists,
general medical practitioners, pharmacists, drug
companies and other agencies dealing with
pharmaceutical administration of the role expected of
physiotherapists by their patients in advising them
appropriately on medications, and more support
provided to physiotherapists by these personnel
regarding access to current drug information.
4. Physiotherapists be educated in a more standard and
comprehensive manner at undergraduate and
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postgraduate training institutions regarding not just
the mechanisms of action of oral and topical NSAIDs,
but also in the quality use of these medicines,
including their side effects and contraindications,
appropriate dosage, interactions with other
medications and appropriateness for particular
conditions.
5. Physiotherapists be provided with the same access to
updated information on NSAIDs as other health
professionals currently licensed to prescribe and
supply these drugs.
6. The particular issues of front-line sports
physiotherapists and rural physiotherapy practitioners
in supplying NSAIDs under specific conditions be
considered by the APA, the registration boards and the
relevant Commonwealth Government departments,
with a view to limited license to prescribe and supply. 
7. Discussions be held between the APA, the registration
boards, Schools of Physiotherapy and relevant
Commonwealth Government departments regarding
responsibility and funding sources to support regular
updates of physiotherapist knowledge on commonly
used pharmaceuticals, in particular NSAIDs. These
updates should pay particular attention to at-risk
groups such as the elderly, and those patients with
chronic and complex conditions. 
8. Opportunities for widespread regular provision of
information to physiotherapists be identified and
utilised, such as the Australian Journal of
Physiotherapy, APA newsletters and professional
conferences. Opportunities for wide debate and
information exchange should also be considered,
particularly when a new NSAID is released, or when a
NSAID is re-scheduled. 
9. More research be undertaken to focus on such issues
as:
• action and penetration of topical NSAIDs under
massage and phonophoresis delivery;
• dose-response of topical NSAIDs for particular
conditions, compared with oral administration,
and with non-medication forms of physiotherapy;
• risks for the physiotherapist associated with
regular delivery of topical NSAIDs via massage;
and
• the educational approaches associated with
sustainable behaviour change and knowledge
uptake, for physiotherapists and patients.
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Appendix
DEMOGRAPHICS
(please tick ✔ the appropriate response)
1. Please tick which state you are from
South Australia ❍ Tasmania ❍ ACT ❍
2. Where are you currently spending most of your
working time?
Hospital inpatients ❍ Private practice ❍ 
Hospital outpatients ❍ Aged and/or 
Community setting ❍ 
Other 
(please describe) ______________________
3. When did you last update your knowledge on
NSAIDs?
Never ❍ 1-5 years ❍ Recently ❍ 5-10 years ❍ 
< 1 year ❍ > 10 years ❍ 
4. Did you actively seek out this information?   
Yes ❍ No ❍
5. How did you obtain this information? 
(tick ✔ as many as you require)
Via another physiotherapist ❍ Journal (academic)
articles ❍ Direct from drug companies ❍ General
medical practitioner ❍ Via the Physiotherapy
Registration Board ❍ Local Pharmacist ❍ Via APA ❍
MIMS ❍ Training schools (eg university) ❍
Advertising campaign ❍ 
Other (please describe) _______________________
CURRENT KNOWLEDGE
1. Where are the following medications obtained?
(please put ticks ✔ in the appropriate boxes)
Super- Pharmacy Pharmacy Doctors’ Don’t
market - over the via Pharm- prescrip- know
counter acist tion
Indocid 
Suppository
Asprin
Voltaren Gel
Feldene gel
Neurofen
ACT 3
Celebrex
Digesic
Voltaren 
tablets       
2. List the risks that you know are associated with the
use of NSAIDs. 
Oral  Topical
3. Legislation allows: (please tick ✔ the appropriate
response)
Physiotherapists to advise on the use of NSAIDs 
Yes ❍  No ❍  Don’t know  ❍ 
Physiotherapists to prescribe NSAIDs 
Yes ❍  No ❍  Don’t know  ❍ 
Physiotherapists to recommend NSAIDs 
Yes ❍  No ❍  Don’t know  ❍ 
Physiotherapists to supply oral NSAIDs
Yes ❍  No ❍  Don’t know  ❍ 
Physiotherapists to supply topical NSAIDs 
Yes ❍  No ❍  Don’t know  ❍ 
Physiotherapists to use NSAIDs in patient treatment
Yes ❍  No ❍  Don’t know  ❍ 
4. List three conditions for which NSAIDs are
recommended as part of management  
1.  
2.  
3.  
5. List three common drugs with which NSAIDs
interact 
1.  
2.  
3.  
6. List three conditions for which NSAIDs may be
contraindicated
1.  
2.  
3.  
7. List common adverse reactions to NSAIDs 
8. Do you know of any of your patients having had
adverse reactions to NSAIDs? 
Yes ❍ No ❍
Briefly describe:
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CURRENT PRACTICE
1. Does your practice/institution have a policy regarding
physiotherapists recommending NSAIDs to patients?
Yes ❍    No ❍    Don’t know ❍ 
If Yes – Do you follow this policy? Yes ❍ No ❍
If No or Don’t know – Do you think such a policy
would be beneficial?  Yes ❍ No ❍ Don’t know ❍
2. Do you commonly recommend NSAIDs to your
patients ?
Yes ❍ No ❍
(tick as many as required)
Over the counter oral medication ❍
Over the counter topical medication ❍
Prescription oral medication ❍
Prescription topical medication ❍
Refer to GP ❍
Refer to pharmacist ❍
3. Do your recommendations on NSAIDs include?
Warnings/advice Yes ❍    No ❍ 
Indications Yes ❍    No ❍ 
Precautions Yes ❍    No ❍ 
Contraindications Yes ❍    No ❍ 
Drug interactions Yes ❍    No ❍ 
Side effects Yes ❍    No ❍ 
Dosage Yes ❍    No ❍ 
Brand names Yes ❍    No ❍
4. Which NSAIDs do you usually recommend?
_________________________________________
5. Do you record any discussions on medications in
your clinical records?                Yes ❍ No   ❍
6. Which of the following sources have you used in the
past six months to find out about NSAIDs?
Current MIMS ❍ 
Drug company information ❍ 
Drug company studies ❍ 
Internet sources on drugs ❍ 
Medical practitioner ❍ 
Pharmacists ❍ 
Research papers ❍ 
Instructions on packets ❍ 
Other ❍ 
None ❍ 
YOUR ATTITUDES TO NSAIDs
1. Do you believe that:
a) physiotherapists should be able to prescribe
NSAIDs 
Yes ❍   No ❍   Don’t know ❍ 
b) your current knowledge of NSAIDs is sufficient
to allow you to advise patients on safe use? 
Yes ❍   No ❍   Don’t know ❍ 
2. Whose responsibility do you think it is, to provide
information on NSAIDs to physiotherapists 
(tick ✔ as many as you wish)?
Physiotherapists should seek it themselves ❍ 
Drug companies ❍ 
Physiotherapy Registration Boards ❍ 
Australian Physiotherapy Association ❍ 
Local pharmacists ❍ 
General practitioners ❍ 
Training schools (eg School of
Physiotherapy/Pharmacy in a university) ❍
Physiotherapy conferences ❍ 
Other (please describe) ❍
3. Could you summarise your attitude towards the place
of NSAIDs in physiotherapy practice?
Thank you for taking the time to complete this
questionnaire. Please return it as soon as possible in
the envelope provided.
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